Internal Reference Number: FOI_7925
Date Request Received: 08/05/2024 00:00:00
Date Request Replied To: 21/05/2024 00:00:00
This response was sent via: By Email
Request Summary: Request on GCA
Request Category: Researcher
| Question Number 1: Does your trust or health board treat giant cell arteritis (GCA)? If not, please provide the name of the hospital or trust that you refer GCA patients to. | |
| Answer To Question 1: Please see our response to all questions of this FOI in the Excel spreadsheet attached. To accompany this answer to question 1 please also see the documents listed below:  FOI_7925 - Giant Cell Arteritis response.xlsx | |
| Question Number 2: In the past 3 months, how many patients with a primary diagnosis of GCA (ICD10 codes M31.5 or M31.6) were: • Admitted as an inpatient • Treated in A&E | |
| Answer To Question 2: Please see our response to all questions of this FOI in the Excel spreadsheet attached. | |
| Question Number 3: How many patients were treated by the rheumatology department in the past 3 months with the following: • Tocilizumab – for any disease • Tocilizumab for rheumatoid arthritis (RA) only • Tocilizumab for giant cell arteritis (GCA) only | |
| Answer To Question 3: Please see our response to all questions of this FOI in the Excel spreadsheet attached. | |
| Question Number 4: How many patients were treated by the ophthalmology department (for any disease) in the past 3 months with Tocilizumab? | |
| Answer To Question 4: Please see our response to all questions of this FOI in the Excel spreadsheet attached. | |
| Question Number 5: How many patients were treated in A&E in the past 3 months for giant cell arteritis (GCA) with Tocilizumab? | |
| Answer To Question 5: Please see our response to all questions of this FOI in the Excel spreadsheet attached. | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
